EUR 32.66
(2.7%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 533.12 Million SEK | 84.12% |
2022 | 25.89 Million SEK | 45.93% |
2021 | 17.74 Million SEK | 10.32% |
2020 | 16.08 Million SEK | 23.83% |
2019 | 12.98 Million EUR | 60.17% |
2018 | 8.1 Million EUR | -29.09% |
2017 | 11.43 Million EUR | 24.11% |
2016 | 9.21 Million EUR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 202.79 Million EUR | 18.73% |
2024 Q3 | 220.62 Million SEK | 8.79% |
2024 Q1 | 14.78 Million SEK | 7.69% |
2023 FY | 47.67 Million SEK | 84.12% |
2023 Q4 | 14.18 Million SEK | 12.76% |
2023 Q1 | 9.58 Million SEK | 13.79% |
2023 Q2 | 10.84 Million SEK | 13.17% |
2023 Q3 | 12.57 Million SEK | 15.93% |
2022 Q2 | 6.17 Million EUR | 7.16% |
2022 FY | 25.89 Million SEK | 45.93% |
2022 Q4 | 8.42 Million EUR | 19.8% |
2022 Q3 | 7.03 Million EUR | 13.88% |
2022 Q1 | 5.76 Million EUR | 8.51% |
2021 Q4 | 5.31 Million EUR | 0.0% |
2021 FY | 17.74 Million SEK | 10.32% |
2020 FY | 16.08 Million SEK | 23.83% |
2019 FY | 12.98 Million EUR | 60.17% |
2018 FY | 8.1 Million EUR | -29.09% |
2017 FY | 11.43 Million EUR | 24.11% |
2016 FY | 9.21 Million EUR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
SCHOTT Pharma AG & Co. KGaA | 316.48 Million EUR | -68.449% |
Carl Zeiss Meditec AG | 1.2 Billion EUR | 55.785% |
Fielmann Aktiengesellschaft | 576.41 Million EUR | 7.51% |
Gerresheimer AG | 597.31 Million EUR | 10.747% |
Sartorius Aktiengesellschaft | 1.56 Billion EUR | 65.98% |
Sartorius Aktiengesellschaft | 1.56 Billion EUR | 65.98% |